Drug Profile
Research programme: antibody-drug conjugates - ABL Bio/LegoChem Biosciences
Alternative Names: ABL 201; ABL 20X; ABL201-20X; LCB14-XXXX - ABL Bio/LegoChem BiosciencesLatest Information Update: 28 Aug 2023
Price :
$50
*
At a glance
- Originator ABL Bio
- Developer ABL Bio; LegoChem Biosciences
- Class Antineoplastics; Drug conjugates; Immunoconjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer